2022 Life Sciences Summit | News | ONE

Sector entrepreneurs, investors, and policymakers will share their insights on how research, innovation and commercialisation in the sector improve lives and livelihoods, deliver economic value, and create jobs for the future.

Keynotes, panel discussions and showcase sessions will explore the latest biotech and healthtech developments, funding and investment for company growth, and what is coming next for this high-value sector regionally and nationally – including the opening of the transformational BioHub in Aberdeen later this year.

The summit speakers include:

• Mark Bamforth, Arranta Bio
• Dr Rabinder Buttar, Clintec International
• Dr Deborah O’Neil, Novabiotics
• Dr Glenn Corr, TauRx
• Dr James McIlroy, EnteroBiotix
• Dr Tiffany Wood, Dyneval
• Prof Andy Porter, Elasmogen
• Dr Clare Wareing, Cumulus Oncology
• Dee Dinneen, Kheiron Medical Technologies
• Dr Ignat Drozdov, Bering
• Dr Andrew Keen, NHS Grampian
• Houman Ashrafian, SV Health Investors
• Dr Martin Turner, UK Bioindustry Association
• Jennifer Craw, Opportunity North East
• Tom Whipple, The Times
• Magnus Llewellin, The Times Scotland
• Jason Allardyce, Sunday Times Scotland

For the full summit agenda, speakers and registration, click here.

Academics, clinicians, companies, researchers and anyone involved in life sciences company creation and growth will find the summit relevant to their interests.

Opportunity North East and BioHub have partnered with The Times and Sunday Times Scotland and the University of Aberdeen to deliver the second Life Sciences Summit in Aberdeen, building on the success of the inaugural summit in February 2020.